Shanghai Haohai Biological Technology Co. Ltd (5HB) — Capital Reinvestment Ratio
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Capital Reinvestment Ratio of 0.37x as of June 2023, meaning it reinvests 0% of its operating cash flow (€141.99 Million) in capital expenditures (€53.01 Million). Check Shanghai Haohai Biological Technology Co tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Haohai Biological Technology Co. Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Shanghai Haohai Biological Technology Co. Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 5HB cash generation efficiency.
Annual Capital Reinvestment Ratio for Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. See Shanghai Haohai Biological Technology Co (5HB) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | €490.97 Million | €186.94 Million | ▼ -32.1% |
| 2024 | 0.56x | €648.57 Million | €363.49 Million | ▲ +3.6% |
| 2023 | 0.54x | €634.45 Million | €343.10 Million | ▼ -59.5% |
| 2022 | 1.34x | €231.30 Million | €309.21 Million | ▲ +68.9% |
| 2021 | 0.79x | €342.29 Million | €270.88 Million | ▲ +9.3% |
| 2020 | 0.72x | €262.07 Million | €189.70 Million | ▲ +1.4% |
| 2019 | 0.71x | €348.91 Million | €249.18 Million | ▲ +84.8% |
| 2018 | 0.39x | €391.28 Million | €151.21 Million | ▼ -1.3% |
| 2017 | 0.39x | €343.06 Million | €134.29 Million | ▲ +31.7% |
| 2016 | 0.30x | €254.49 Million | €75.67 Million | — |